US names comparative effectiveness research council
This article was originally published in Scrip
Executive Summary
US FDA biologics centre director Dr Jesse Goodman, currently serving as the agency's acting chief medical officer, will represent the medicines regulator on a federal council charged with co-ordinating $1.1 billion in comparative effectiveness research under the recent economic stimulus law.